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Abstract
Mutations in the Tre2/Bub2/Cdc16 (TBC)1 domain family member 24 (TBC1D24) gene are associated with a range of inherited
neurological disorders, from drug-refractory lethal epileptic encephalopathy and DOORS syndrome (deafness,
onychodystrophy, osteodystrophy, mental retardation, seizures) to non-syndromic hearing loss. TBC1D24 has been
implicated in neuronal transmission and maturation, although the molecular function of the gene and the cause of the
apparently complex disease spectrum remain unclear. Importantly, heterozygous TBC1D24 mutation carriers have also been
reported with seizures, suggesting that haploinsufficiency for TBC1D24 is significant clinically. Here we have systematically
investigated an allelic series of disease-associated mutations in neurons alongside a new mouse model to investigate the
consequences of TBC1D24 haploinsufficiency to mammalian neurodevelopment and synaptic physiology. The cellular
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studies reveal that disease-causing mutations that disrupt either of the conserved protein domains in TBC1D24 are
implicated in neuronal development and survival and are likely acting as loss-of-function alleles. We then further
investigated TBC1D24 haploinsufficiency in vivo and demonstrate that TBC1D24 is also crucial for normal presynaptic
function: genetic disruption of Tbc1d24 expression in the mouse leads to an impairment of endocytosis and an enlarged
endosomal compartment in neurons with a decrease in spontaneous neurotransmission. These data reveal the essential
role for TBC1D24 at the mammalian synapse and help to define common synaptic mechanisms that could underlie the
varied effects of TBC1D24 mutations in neurological disease.
Introduction
The regulation of synaptic transmission is a key pathological
mechanism in disease, with mutations in genes that mediate
the synaptic vesicle (SV) cycle joining an ever-expanding group
of neurological disorders recently termed as the synaptopathies
(1,2). These disorders include inherited forms of epilepsy
caused by presynaptic proteins such as MUNC18–1 [encoded
by syntaxin-binding protein 1 (STXBP1)] (3,4), Synapsin I (SYN1)
(5,6), syntaxin 1B (STX1B) (7,8) and synaptosome-associated
protein 25B (SNAP25B) (9), and there are clues from studies
in model organisms that many more SV-associated genes will
play a central role in diseases characterized by seizures and/or
neurodevelopmental delay (10,11).
One of the more recently discovered causes of familial
epilepsy is the Tre2/Bub2/Cdc16 (TBC)1 domain family member
24 (TBC1D24) gene; over 50 mutations are now associated
with a range of inherited neurological disorders, including
myoclonic epilepsy, epileptic encephalopathy and DOORS
syndrome (deafness, onychodystrophy, osteodystrophy, mental
retardation and seizures) (12,13). Additional clinical features
reported include neurodevelopmental delay, neurodegeneration
and non-syndromic hearing loss (12). However, despite the
obvious pleiotropic effects of TBC1D24 mutations, no clear
phenotype–genotype correlation is apparent to date (13).
Initial functional studies demonstrated that the Drosophila
TBC1D24 orthologue, skywalker (sky), regulates the size and
content of endosome-dependent SV pools at the larval neu-
romuscular junction (NMJ), with loss of sky leading to increased
neurotransmission (14,15). Most recently, a cationic phospho-
inositide binding pocket was identified in the sky N-terminal TBC
domain and the accumulation of endosomal vesicles alongside
seizure-related phenotypes were observed in flies expressing
certain DOORS-associated mutations at positions that were
conserved in Drosophila (16). In rodent systems, acute knockdown
of Tbc1d24 perturbs the migration and dendritic arborization of
cortical pyramidal neurons, while conversely, overexpression
of Tbc1d24 induces neurite outgrowth and differentiation; both
these particular functions were suggested to be mediated by
the TBC domain acting as a modulator of Rab-GTPase activity
(13,17–19). In addition, TBC1D24 has been implicated in oxidative
stress resistance and cell survival via the highly conserved
C-terminal TLDc domain that is shared with a family of proteins
including oxidation resistance 1 (OXR1) and nuclear receptor co-
activator 7 (NCOA7) (20,21). Yet, despite these data, the molec-
ular function of TBC1D24 is still unclear, particularly when
considering the distinct roles of the two conserved protein
domains and the potential for allosteric interactions between
them. Furthermore, the effects of TBC1D24 disruption on
synapse biology is yet to be studied in a mammalian genetic
system.
The predominance of recessive and compound heterozy-
gous disease mutations in TBC1D24 - often with premature
termination mutations leading to nonsense-mediated decay in
some cases - suggests a loss-of-function mechanism, and this
is supported by the significant reduction of TBC1D24 protein
expression in patient cells (22,23). Importantly, individuals with
heterozygous TBC1D24 mutations - often relatives of more
severely affected individuals - have also been reported with
seizures, suggesting that haploinsufficiency for TBC1D24 can
be detrimental (13,24–27). Further evidence for the significance
of TBC1D24 haploinsufficiency is provided by the very recent
description of heterozygous microdeletions spanning TBC1D24
and a small number of adjacent genes; these individuals display
epilepsy, microcephaly and developmental delay (28).
How such mutations influence the multiple functions of
this gene in neuronal cell survival and synaptic function is
unknown. Therefore, here we have systematically analysed
disease-associated mutations in neurons combined with the
study of synaptic physiology in the first mouse model of TBC1D24
haploinsufficiency; our data demonstrate that the TBC and
TLDc domains are both functionally implicated in neuronal
development and survival and that TBC1D24 is essential for
normal presynaptic function in vivo.
Results
TBC1D24 is unique in a sense that it contains both a TBC
and TLDc domain, yet the functional significance of this
architecture in relation to disease-causing mutations is not
understood. We mapped TBC1D24 mutations onto a new
structural prediction of the human TBC and TLDc domains,
suggesting that there is no obvious clustering of a certain clinical
sub-type or severity (Fig. 1A). To quantify this assumption,
the distance between disease-associated amino acids was
calculated based on a new model of the TBC domain, and no
disease appears to be associated to mutations in a specific
protein region (Supplementary Material, Fig. S1). Therefore,
we next utilized a systematic experimental approach to study
the functional impact of a series of disease mutations on two
key cellular parameters known to be influenced by TBC1D24,
oxidative stress resistance (20) and neurite outgrowth (17,18).
As the functional data available in mammalian systems to
date have been limited to acute embryonic knockdown or
overexpression studies in wild-type (WT) rodent tissues or
cells, we chose to generate a CRISPR-Cas9-mediated TBC1D24
knockout neuronal cell line (Tbc1d24Δ/Δ) and studied the
expression of an allelic series TBC1D24 mutants compared
to WT TBC1D24. Mutants were selected to represent a broad
clinical spectrum of recessively inherited mutations, as well as
spanning the full length of the protein including both conserved
domains (Fig. 1B). Mutants represented DOORS syndrome (R40L
and R242C), infantile myoclonic epilepsy (R270H), early-onset
epileptic encephalopathy (S324X) and progressive myoclonic
epilepsy with neurodegeneration (R360L) (12,13). Hence, this
approach not only avoids the confounding, compensatory effects
of endogenous WT TBC1D24 present in the system, but also
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Figure 1. Disease-causing mutations in TBC1D24 influence neuronal cell differentiation and sensitivity to oxidative stress. (A) Three-dimensional structural model of
TBC1D24 indicating the positions of published pathogenic mutations classified into three general disease classes (yellow, red, blue) as shown (12,13). E549, the most
conserved residue of the TLDc domain is also shown (white). (B) The TBC1D24 mutations investigated in this study include those situated just before (R40L) and within
the TBC (R242C) domain and in the TLDc domain (R360L). S324X represents a frame-shift mutation (S324Tfs∗3) that results in a premature stop codon (12,13). The E549A
mutation has been described previously as disrupting the function of TBC1D24 (20). (C) Western blot demonstrated a complete loss of TBC1D24 protein expression in
CRISPR-deleted N2a cells (Tbc1d24Δ/Δ). GAPDH was used as a loading control. (D,E) Untransfected Tbc1d24Δ/Δ cells were more sensitive to arsenite treatment than
control N2a cells (D) and grew shorter neurites (N > 100 neurites from 3 independent experiments) (E). (F,G) Tbc1d24Δ/Δ cells transfected with TBC1D24 mutants
presented an increased sensitivity to arsenite treatment compared to Tbc1d24Δ/Δ cells transfected with WT TBC1D24 (F) and grew shorter neurites (G), similar to cells
transfected with an empty control vector (N > 70 neurites). All data are expressed as mean ± SEM. (F,G) ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ANOVA followed by Dunnett’s
multiple comparison test compared to TBC1D24 WT vector. #P < 0.05; ##P < 0.01; ###P < 0.001; ANOVA followed by Dunnett’s multiple comparison test compared to
empty vector. (D,E) Unpaired t-test.
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allows us to assess potential correlations between genotype and
phenotype across two key functional parameters.
We first confirmed that the Tbc1d24Δ/Δ Neuro2a (N2a) cell
line lacked any TBC1D24 at the protein level (Fig. 1C). Impor-
tantly, these cells were not only viable, but they also demon-
strated reduced survival under oxidative stress (Fig. 1D) and grew
shorter neurites when differentiated compared to control cells
(Fig. 1E). Thus, this cell line facilitates comparative studies of
phenotypic rescue by exogenous expression of WT TBC1D24
versus disease mutants. Firstly, for oxidative stress resistance,
expression of WT TBC1D24 in the Tbc1d24Δ/Δ line was able to
significantly prevent cell death versus an empty negative control
vector (Fig. 1F). As an additional control for this assay, expression
of TBC1D24 with a mutation in a highly conserved amino acid
proven to abolish the protective function of the TLDc domain
was tested (E549A) (20); as expected, this mutation prevented any
protection against oxidative stress-induced cell death (Fig. 1F).
For the disease-causing mutations, expression of the TBC1D24
truncation mutant (S324X) also conferred virtually no protection
against cell death compared to WT TBC1D24 (Fig. 1F). All of
the remaining mutants resulted in significantly higher cellular
survival compared to the empty vector control, yet none were
as protective as expression of the WT protein (Fig. 1F). Secondly,
for the analysis of neuronal differentiation, WT TBC1D24 was
able to induce neurite outgrowth successfully in Tbc1d24Δ/Δ cells
(Fig. 1G). All of the TBC1D24 mutants tested resulted in some
reduction in the efficiency of outgrowth induction, with expres-
sion of four of the disease-causing mutations leading to sig-
nificantly shorter neurite length than WT TBC1D24 expression
(Fig. 1G). We also confirmed that these findings were not likely
due to variable expression of the exogenous WT and mutant
TBC1D24 proteins in N2a cells (Supplementary Material, Fig. S2).
Taken together, these data demonstrate that in the absence of
WT TBC1D24, expression of all the mutations tested here lead to
at least a partial loss-of-function of TBC1D24, both in terms of
oxidative stress resistance and neurite outgrowth. Furthermore,
the influence of mutations on these key cellular parameters is
not confined to a particular region or domain of the TBC1D24
protein sequence.
To investigate further the consequences of TBC1D24 loss-
of-function and haploinsufficiency in vivo, we chose to use a
viable mammalian genetic system as none have been described
to date. Therefore, we utilized a mouse model harbouring one
copy of a disrupted Tbc1d24 allele (Tbc1d24tm1b). These mice
express approximately half the level of TBC1D24 compared to
WT controls (Tbc1d24WT) at both the RNA and protein level
(Fig. 2A–C). Considering that Tbc1d24 has been implicated pre-
viously in neuronal migration, and that human TBC1D24 muta-
tions can cause neurodevelopmental delay, we assessed initially
the early postnatal period in Tbc1d24tm1b mice. The gross struc-
ture of the brain appeared normal in Tbc1d24tm1b animals, and
quantification of layer markers in the somatosensory cortex
and cell numbers in the hippocampus did not indicate any
migration defects or neurodegeneration in mutants compared
to Tbc1d24WT mice (Supplementary Material, Fig. S3). In addition,
assessment across the neonatal period showed that Tbc1d24tm1b
mice showed normal growth patterns, and behavioural analy-
ses demonstrated that mutants reached key neurodevelopmen-
tal milestones at the same time as controls (Supplementary
Material, Fig. S4).
One of the recurrent clinical features of individuals with
TBC1D24 mutations is deafness; therefore, we also analysed
auditory function and the ultrastructure of the inner ear in
Tbc1d24tm1b mice. First, auditory brainstem response (ABR)
recordings were carried out and no differences in auditory
threshold were detected between genotypes (Supplementary
Material, Fig. S5A). Considering that TBC1D24 is reported to
be expressed specifically in the inner hair cells of the cochlea
in neonatal mice (29), we next analysed the position and
structure of these stereocilia by scanning electron microscopy
(SEM) and these data indicated that there was no disorgani-
zation or loss of the cochlea hair cell bundles in Tbc1d24tm1b
mice (Supplementary Material, Fig. S5B–E). Thus, combined
with the normal ABR thresholds observed, our findings sug-
gest that there is no auditory dysfunction in Tbc1d24tm1b
mutants.
Our in vitro data demonstrate that TBC1D24 has an impor-
tant influence on cellular survival and differentiation. Therefore,
to determine the potential significance of Tbc1d24 haploinsuf-
ficiency to neuronal development and response to oxidative
stress, we next analysed the properties of primary neurons
from Tbc1d24tm1b mice. Hippocampal and cortical neurons from
Tbc1d24tm1b mutants were analysed at 5 days in vitro (DIV) and
showed significantly reduced dendritic and axonal growth com-
pared to WT controls (Fig. 2 D–F, H, I). Furthermore, primary neu-
rons from both the hippocampus and cortex of Tbc1d24tm1b mice
displayed an increased sensitivity to oxidative stress-induced
cell death compared to WT controls (Fig. 2G, J). Therefore, despite
generally normal neurodevelopment in mutant mice, the genetic
disruption of Tbc1d24 has a clear impact on the maturation and
oxidative stress resistance of neurons.
Studies in the fly suggest that disruption of the TBC1D24
orthologue, sky, influences aspects of neurotransmission at
NMJs (14), yet very little is known about the role of TBC1D24 in
mammalian synaptic physiology that might explain the range
of clinical outcomes observed in patients. Therefore, we next
analysed primary neurons from Tbc1d24tm1b mice in detail to
determine whether haploinsufficiency for the gene would cause
abnormalities in synaptic structure and function. First, the
intrinsic excitability of Tbc1d24tm1b and Tbc1d24WT hippocampal
excitatory neurons was measured at 14 DIV by current-clamp
recordings while depolarizing the membrane potential with
subsequent current steps (Fig. 3A, B). Both genotypes generated
very similar spike trains, with no significant difference in both
action potential (AP) rates versus injected current and average
instantaneous frequency (Fig. 3A, B). Next, we tested whether
excitatory neurotransmission was affected in Tbc1d24tm1b hippo-
campal neurons. Miniature excitatory post-synaptic currents
(mEPSCs) were continuously recorded at the soma of voltage-
clamped neurons held at −70 mV (Vh) in the presence of
tetrodotoxin (TTX) to block spontaneous APs, and the mEPSC fre-
quency fell almost 3-fold in Tbc1d24tm1b compared to Tbc1d24WT
neurons (Fig. 3C). Although this effect was accompanied by
a slight but significant decrease in the mean peak current
amplitude, the synaptic charge was not altered (Fig. 3D, E).
Cumulative analysis confirmed the selective defect in mEPSC
frequency in Tbc1d24tm1b neurons, with no marked effects on
the distribution of the current amplitude (Fig. 3F). In principle,
these findings could be attributable to either abnormal neuronal
maturation resulting in a reduced density of synaptic contacts
or abnormal release properties. To test the former hypothesis,
the number of synaptic boutons was quantified in parallel
hippocampal cultures by co-staining with the presynaptic
marker v-GLUT1 and the post-synaptic marker Homer1, and
no difference in synaptic density was observed between
genotypes (Fig. 3G). Together, these data suggest that TBC1D24
is required to maintain the normal function of excitatory nerve
terminals.
D
ow
nloaded from
 https://academ
ic.oup.com
/hm
g/advance-article-abstract/doi/10.1093/hm
g/ddy370/5134216 by guest on 15 January 2019
Human Molecular Genetics, 2018, Vol. 00, No. 00 5
Figure 2. Genetically reduced levels of Tbc1d24 expression alters primary neuronal maturation and survival. (A) In situ hybridization demonstrating a reduction in
Tbc1d24 expression in the postnatal (P15) mouse brain from Tbc1d24tm1b mice versus littermate Tbc1d24WT controls. Scale bar: 0.5 mm. A significant reduction in
expression in the hippocampus at P15 is confirmed by qRT-PCR (N = 3 animals of each genotype) (B) and western blot (N = 5 animals of each genotype) (C); GAPDH
was used as a loading control. (D) Representative immunostaining of primary hippocampal cultures from Tbc1d24WT or Tbc1d24tm1b with dendritic (Map2) and axonal
(Tau) markers. Scale bar: 100 μM. (E,F) Quantification of dendrite (E) and axonal (F) length in hippocampal neurons (N > 100 axons/dendrites from 3 independent
preparations of each genotype). (G) In the same cultures, the number of apoptotic cells was quantified by cleaved caspase-3 immunostaining after arsenite treatment
to induce oxidative stress. (H,I) Quantification of dendrite (H) and axonal (I) length in primary cortical (N > 100 axons/dendrites from 4 independent preparations of
each genotype). (J) In the same cultures the number of apoptotic cells was quantified as in (G). Data are expressed as the mean ± SEM. (B, C, E–J) ∗P < 0.05; ∗∗P < 0.05;
∗∗∗P < 0.001 unpaired t-test compared to Tbc1d24WT .
Given these findings, alongside the consistent presence
of TBC1D24 at the mammalian synapse (30,31), we went on
to investigate the presynaptic role of TBC1D24. Initially, we
transfected primary hippocampal neurons at the same develop-
mental stages used for patch clamp recordings with a synapto-
pHluorin (SypH2x) probe to dissect the significance of TBC1D24
to the exo-endocytotic cycle of SVs. First, stimulation with 100
APs at 10 Hz was carried out as an initial measure of basal
exocytosis of the readily releasable pool (RRP). No difference in
the mean peak fluorescence and in the time constant of post-
stimulus endocytosis was observed between Tbc1d24tm1b and
Tbc1d24WT cells, suggesting no defect in the extent and kinetics
of exo-endocytosis following a short stimulus (Fig. 4A). Next, a
longer stimulation (300 APs at 10 Hz) was employed to mobilize a
larger SV pool. As previously, the peak amplitude was unaltered
between genotypes, yet importantly, the post-stimulus decay
traces revealed a significantly slower time course of endocytosis
in mutant cells versus Tbc1d24WT controls (Fig. 4B, C). We
also investigated during-stimulus endocytosis using the drug
folimycin to block SV re-acidification (32). Cells were stimulated
initially at 10 Hz for 30 s without folimycin, allowed to rest,
followed by a further 120 s at 10 Hz in the presence of
the drug (Fig. 4D). As expected, in Tbc1d24WT neurons, the
folimycin treatment increased the response to a 30 s stimulus
compared to untreated cells as a measure of active, during-
stimulus SV recycling (Fig. 4D). Strikingly, this increase in the
response was almost absent in Tbc1d24tm1b neurons, suggesting
a significant recycling deficit during stimulation (Fig. 4D). To
further quantify the time course of net endocytosis during
stimulation, the difference between the data acquired in the
absence or presence of folimycin was calculated, revealing
a strong (>3-fold) reduction in endocytic rate in Tbc1d24tm1b
compared to Tbc1d24WT cells (Fig. 4E). Calculating the magnitude
of endocytosis during the 300 AP protocol revealed a significant
4- to 5-fold reduction in mutant neurons compared to controls
(Fig. 4F).
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Figure 3. Genetic disruption of Tbc1d24 expression results in decreased mEPSC frequency with no effect on excitatory synapse number in hippocampal primary neurons.
(A) Representative current-clamp recordings of spike trains evoked by somatic current injection of 300 pA for 500 ms from hippocampal WT Tbc1d24WT (black) and
mutant Tbc1d24tm1b (red) mice. (B) AP in 500 ms (or mean firing frequency in Hz) versus injected current (pA; left) and averaged instantaneous frequency at 300 pA
(right) (N = 31 neurons from 4 independent preparations). (C) Representative traces of mEPSCs recorded at −70 mV in 14 DIV hippocampal neurons from Tbc1d24WT
(black) and Tbc1d24tm1b (red) mice. (D) Histograms showing average peak frequency and amplitude of mEPSCs. (E) Average amplitude of mEPSCs calculated as peak
area. (F) Cumulative plot of peak frequency (left) and amplitude (right) showing a selective defect in the peak frequency (N = 25 and 27 neurons from Tbc1d24WT
and Tbc1d24tm1b mice respectively from 4 independent preparations). (G) Representative images of Tbc1d24WT and Tbc1d24tm1b hippocampal culture immunolabelled
with the glutamatergic presynaptic and postsynaptic markers v-GLUT1 and Homer1. Nuclei are stained with DAPI. Number of v-GLUT1 and Homer1 positive puncta
are automatically counted and normalized to the number of cells in the field (N = 28–24 fields per experimental condition from 3 independent preparations).
Scale bar: 20 μM. All data are expressed as the mean ± SEM. (B, D, E, G) ∗P < 0.05; ∗∗∗P < 0.001; unpaired t-test.
To address whether these functional defects caused by
TBC1D24 haploinsufficiency were accompanied by modification
in SV distribution at the synapses, we studied the synaptic ultra-
structure by transmission electron microscopy (TEM) (Fig. 5A).
Conventional TEM analysis of nerve terminals from Tbc1d24tm1b
mice revealed a preserved density of total as well as docked
SVs with respect to Tbc1d24WT neurons (Fig. 5B, C), whereas a
significant increase in the density of endosomal-like structures
was observed in mutants (Fig. 5D). To investigate this further,
three-dimensional reconstructions of nerve terminals were
carried out (Fig. 5E). Interestingly, these data suggested that
while the number of SVs, docked SVs and endosome-like
structures in Tbc1d24tm1b were unaffected (Fig. 5F–H), a striking
3-fold increase in the endosomal volume was observed (Fig. 5I).
In summary, our data from the Tbc1d24tm1b model of TBC1D24
haploinsufficiency indicate an important function for the gene
in neuronal development and survival alongside a critical role
in presynaptic SV recycling in mammalian neurons.
Discussion
Here we have established the essential role of TBC1D24 at the
mammalian synapse, revealing that genetic conditions mirror-
ing haploinsufficiency in TBC1D24 patients lead to defects in
neuronal development, spontaneous neurotransmission and SV
recycling. We began by surveying disease mutations throughout
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Figure 4. Genetic disruption of Tbc1d24 expression results in defective endocytosis in primary neurons. (A) Average fluorescence traces of hippocampal neurons at 15
DIV expressing the pHluorin SypH 2× in response to 100 stimuli at 10 Hz [N = 188 boutons from 8 coverslips (Tbc1d24WT) or 87 boutons from 5 coverslips (Tbc1d24tm1b)]
indicating no difference in the post-stimulus endocytic time constant. (B) Normalized average traces of neurons expressing SypH 2x in response to 300 stimuli at 10 Hz.
(C) Comparison of average post-stimulus endocytic time constants following the 300 AP stimulus. The decay phases of F traces were fitted with single exponential
functions before normalization and the time constants were calculated from the fits [N = 113 boutons from 5 coverslips (Tbc1d24WT) or 190 boutons from 6 coverslips
(Tbc1d24tm1b)]. (D) Time course and extent of endocytosis during neuronal activity were measured using folimycin (Fol). Neurons expressing SypH 2× were stimulated
at 10 Hz for 30 s in the absence of Fol. After a 10 min rest, neurons were stimulated at 10 Hz for 120 s in the presence of Fol. Images were acquired during each phase
of stimulation. Graph shows average SypH 2× traces from Tbc1d24WT neurons in response to each stimulus. All values were normalized to the maximum fluorescence
change at the end of 1200 stimuli in presence of Fol. The short and long vertical arrows indicate the extent of endocytosis and exocytosis at the end of the 300 stimuli
(vertical dashed line) at 10 Hz, respectively (N = 162 boutons from 5 coverslips). The same experiment was repeated in Tbc1d24tm1b neurons (N = 200 boutons from
6 coverslips). (E) Time courses of during-stimulus endocytosis for Tbc1d24WT and Tbc1d24tm1b neurons during stimulation (30 s, 10 Hz). Each endocytosis time-course
was calculated by subtracting the SypH 2× trace that was acquired in the absence of Fol, from the Fol trace in (D). These traces were fitted with linear functions, the
slope of which corresponds to the endocytic rate in arbitrary units per second. (F) Average magnitude of endocytosis calculated during delivery of 300 pulses. Data are
expressed as the mean ± SEM. (C,F) ∗∗P < 0.01; ∗∗∗P < 0.001; unpaired t-test.
the TBC1D24 protein and demonstrated that all were likely to
act as loss-of-function alleles when the endogenous protein was
absent. It is noteworthy that the TBC and TLDc domains have
been associated with independent functions, including lipid
membrane association (16) and oxidative stress resistance (20),
respectively. Crucially, our new data reveal that the function of
both domains must be considered in concert with respect to neu-
ronal development and survival, demonstrating the complexi-
ties of genotype–phenotype correlations in TBC1D24-associated
diseases. Indeed, there are several clinical examples of biallelic
TBC1D24 mutations—one in each domain—where the disease
phenotype is more severe than those that are monoallelic (12).
Thus, the availability of a three-dimensional structure of the
entire human protein will facilitate future predictions regarding
potential allosteric interactions between the domains, as well
as the phenotypic outcomes of specific pathogenic variants.
For example, our discovery that disease-causing mutations in
both the TBC and TLDc domains can influence cellular survival
is pertinent to the neurodegeneration observed in a subset of
TBC1D24 patients (12,13,33), in addition to a proposed role for
oxidative stress in epilepsy (34).
Our new insights into TBC1D24 function at the mammalian
synapse share some important parallels with previous work on
this protein and its orthologues, although some key differences
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Figure 5. Genetic disruption of Tbc1d24 expression results in increased endosomal volume in primary neurons. (A) Representative TEM images of synapses of cultured
cortical neurons from WT Tbc1d24WT and mutant Tbc1d24tm1b mice, fixed at 17 DIV. Scale bar: 200 nm. (B–D) Conventional TEM analysis of nerve terminals from
Tbc1d24tm1b (red bars) revealed a preserved density of both total (H) and docked (I) SVs with respect to control neurons (black bars), with a significant increase in
the density of endosomal-like structures. (E) Three-dimensional reconstructions of synaptic terminals from serial ultrathin sections; shown are representative three-
dimensional reconstructions from 60 nm-thick serial sections obtained WT Tbc1d24WT and mutant Tbc1d24tm1b synapses. Total SVs and SVs physically docked at the
AZ are depicted as blue and yellow spheres, respectively. The AZ and endosomes are shown in red and black, respectively. Scale bar, 200 nm. (F–H) Ultrastructural
morphometric analysis of three-dimensionally reconstructed synapses displayed similar amount of both total (F) and docked (G) SVs and endosomal number (H). (I)
The endosomal-like volume was calculated from each 2D analysis of synaptic profile and is expressed as mean ± SEM area of endosomes per μm3. Nerve terminal
areas and AZ lengths were similar in the two experimental groups (N = 105 and 126 synapses for Tbc1d24WT and Tbc1d24tm1b, respectively, from three independent
preparations). Data are expressed as the mean ± SEM. (D, I) ∗P < 0.05; Mann–Whitney test.
are apparent that likely reflect the experimental approaches
used in the earlier studies. Acute knockdown of rat Tbc1d24
results in cortical migration deficits (17), although the lack of a
similar phenotype in Tbc1d24tm1b mice after constitutive genetic
disruption in vivo may be the result of functional compensa-
tion during early neurodevelopment. Acute Tbc1d24 knockdown
also resulted in decreased spontaneous neurotransmission but
alongside a reduction in glutamatergic synapse density (17); yet,
these data must be considered in the context of a surrounding
population of WT cells unlike the genetic model we present
here. In loss-of-function models of the Drosophila orthologue sky,
initial studies revealed an increased RRP of SVs at the NMJ with
a concomitant increase in spontaneous activity (14); both are
ultrastructural and physiological features that differ from our
Tbc1d24tm1b model. Functionally, it was proposed that sky acts
as a GTPase-activating protein for Rab35 and this underlies the
endosomal-mediated quality control of SV proteins; currently, it
is unknown whether this mechanism is conserved at a mam-
malian synapse with a larger complement of synaptic regulatory
proteins. Interestingly, TBC1D24 was proposed to regulate the
activation state of ADP-ribosylation factor 6 (ARF6) (17,18), and
the slowed kinetics of SV recycling observed in Tbc1d24tm1b neu-
rons is reminiscent of acute Arf6 silencing (32). Thus, TBC1D24
could act as a regulatory hub for GTPases, which in turn differ-
entially drives SV trafficking dependent on the cellular context;
indeed, the common identification of an enlarged endosomal-
like compartment in both Tbc1d24tm1b and sky mutants further
supports a vital role for TBC1D24 in the dynamic regulation
of SV recycling. Moreover, ARF6-dependent trafficking has been
recently implicated in inner-ear hair cell function, suggesting
that membrane trafficking defects in hair cells can be implicated
in TBC1D24-associated deafness (35).
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Our new findings define the significance of TBC1D24 for
mammalian presynaptic function, and reveal that even partial
loss-of-function mutations are likely to influence fundamental
aspects of SV trafficking. These data place TBC1D24 alongside
other more established synaptic proteins that are mutated in
genetic forms of epilepsy but also play key roles in pathways
essential for neurotransmission and synaptic homeostasis; for
example, loss-of-function mutations in STXBP1 and SYN1 cause
seizures and neurodevelopmental delay including autism in
some SYN1 cases (4,6,36), and mutations in STX1B are associated
with febrile epilepsy syndrome and myoclonic epilepsy (7,8). Fur-
thermore, proteins more recently defined as being important for
synaptic function can also result in pleiotropic clinical effects,
such as proline-rich transmembrane protein 2 (PRRT2), where
multiple mutations are associated with a range of disorders
that include familial infantile seizures, paroxysmal kinesigenic
dyskinesia and hemiplegic migraine (37). More specifically, we
show here that TBC1D24 possesses new functional similarities
to proteins such as activating protein 2 (AP-2) that are essential
for maintaining endosomal dynamics in the nervous system (38).
Despite these well-studied examples, there is still much to learn
regarding the molecular mechanisms that underlie the function
of presynaptic proteins in disease, particularly when a spectrum
of disease type and severity is caused by mutations in the same
gene. Our new data therefore help to establish common synaptic
mechanisms that could underlie the varied effects of TBC1D24
mutations in disease.
Materials and Methods
Animals
Mice were housed with ad libitum access to food and water
on a 12:12 light–dark cycle. Tbc1d24tm1a(EUCOMM)Hmgu mice were
generated as part of the large-scale mouse knockout programme
(39) with loxp sites flanking exons 3–5 of the gene (Ensem-
ble reference ENSMUST00000097376.9). Tbc1d24tm1a(EUCOMM)Hmgu
animals were crossed with mice expressing a ubiquitous cre-
recombinase (C57BL6/J background) to generate Tbc1d24tm1b
mutants in which the first 380 amino acids of the Tbc1d24
protein sequence are deleted from the mutant allele in all
tissues. Complete cre-mediated generation of the tm1b allele
was confirmed by genotyping from genomic DNA samples
from ear clips and confirmed in brain tissue. Tbc1d24tm1b mice
were backcrossed to C57BL6/J for a further six generations.
All experiments were conducted from mice carrying a single
Tbc1d24tm1b allele crossed to WT C57BL/6 J animals to generate
the experimental cohorts. Experimenters were blinded to the
genotypes for all experiments. All experiments were carried out
under the UK (Home Office) regulations (Home Office Licence
PPL 30/3353 held by Peter Oliver) and the guidelines established
by the European Communities Council (Directive 2010/63/EU
of March 4th, 2014) approved by the Italian Ministry of Health
(authorization n. 73/2014-PR and n. 1276/2015-PR).
Antibodies and reagents
The antibodies used are as follows: Actin (Abcam ab8226),
Gapdh (Biolegend 919501 and Covance MMS580S), HA (Sigma
H6908 and Roche 11867423001), Tbc1d24 (Abcam ab101933 and
Aviva ARP57438), MYC (Sigma M4439), Map2 (Millipore AB5622),
Tau (Millipore MAB3420), NF200 (Sigma N4142), vGLUT1 (Synap-
tic System 135303), Homer1 (Synaptic System 160011), NeuN
(Millipore ABN91), Ctip2 (Abcam ab18465), Cux1 (Abcam
ab140042), cleaved caspase-3 (Cell Signaling Technology 9661)
and Tbr1 (Abcam ab31946) and anti-mouse, anti-rat or anti-
rabbit Alexa 594 or Alexa 488 for secondary antibodies (Life
Technologies). All reagents for cell culture were from Gibco,
unless otherwise specified.
Constructs and mutagenesis
Human TBC1D24 and the associated disease or experimental
mutations were expressed from a pcDNA3.1 vector (Invitrogen)
as previously described (13).
Cell culture and neurite growth and cell death assay
Neuro-2a (N2a) cell lines were maintained as a monolayer in
DMEM medium containing glutamax supplemented with 10%
fetal calf serum (FCS), 100 unit/ml penicillin and 100 μg/ml
streptomycin at 37◦C in a humidified atmosphere of 5% CO2.
N2a cells were plated on coverslips pre-treated with poly-
ornithine. Cells were transfected the following day using
Fugene 6 (Promega) as per manufacturer’s protocol. For neurite
growth assay, culture medium was replaced with FCS-free
culture medium before transfection for 48 h to induce neurite
differentiation and growth. Neurite length was measured using
ImageJ software (National Institutes of Health). For cell death
assay, after 48 h transfection, culture medium was replaced with
fresh complete medium containing either vehicle or arsenite
(Sigma, 250 μm) for 5 h. Pyknotic nuclei were visualized by DAPI
staining. Percentage of cell death was calculated as the number
of pyknotic nuclei over the total number of nuclei in one field of
view.
Cortical and hippocampal cell culture
Cortices and hippocampi from Tbc1d24WT and Tbc1d24tm1b
postnatal day 1 (P1) mouse pups were dissected and meninges
removed in cold Hanks’ Balanced Salt solution. Cortices were
incubated in trypsin for 15 min at 37◦C, followed by 5 min of
incubation at room temperature with trypsin inhibitor (Life
Technologies), and triturated to dissociate cells. Cortical neurons
were plated on poly-ornithine pre-coated glass coverslips in
culture medium (Neurobasal-A, 2% FCS, 2% B27, 1% L-glutamine).
Hippocampi were incubated in diluted trypsin (1:50) in HBSS for
10 min at room temperature before 1 ml of culture medium
(Neurobasal-A, 2% FCS, 2% B27, 1% L-glutamine) was added and
hippocampi were triturated. Hippocampal neurons were plated
on coverslips pre-coated with PDL (Sigma) and Fibronectin
(Sigma). Half the culture medium was changed every other day.
Neurons were cultured in vitro for 5 days before assessing neurite
outgrowth or cell death after treatment with vehicle or arsenite
(Sigma, 150 μm for 4 h).
Western blotting
For protein extracts, brains or cells were homogenized in RIPA
buffer (150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate,
0.1% SDS, 50 mM Tris pH 7.5, all Sigma) complemented with
protease inhibitor cocktail (Cell signalling) with ceramic beads
(Precellys; for tissue). Extracts were incubated for 30 min on ice
and centrifuged at maximum speed for 30 min at 4◦C to clear
protein extracts. Protein concentration was quantified using a
Pierce BCA assay (ThermoScientific). Proteins were run on pre-
cast NuPAGE Bis-Tris gels (Invitrogen) and transferred as per the
manufacturer’s protocol.
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In vitro immunocytochemistry
Neurons were washed once in PBS and fixed with 4% paraformal-
dehyde (PFA) for 15 min at room temperature. Cells were blocked
with blocking buffer [5% goat serum (Vector Labs), 0.5% triton
X-100] in PBS for 1 h at room temperature and incubated with
primary antibodies overnight at 4◦C, followed by incubation with
secondary antibodies for 2 h at room temperature. Staining was
visualized using a fluorescence microscope (Leica).
Generation of Tbc1d24/ N2A cell lines
Cells were generated using a CRISPR-Cas9 strategy: single
guide RNAs (sgRNAs) target sites were selected within the
mouse Tbc1d24 coding sequence using the CRISPR design
tool (crispr.mit.edu) to minimize potential off-targets. sgRNA
sequences were cloned into the puromycin cassette-containing
pX459 vector (Addgene #62988, a kind gift of Feng Zhang)
as annealed pairs of 24 nt oligos into the Bbs I site, and
tested for efficacy by transfection into N2A neuroblastoma
cells using Fugene 6 (Promega) followed by high-resolution
melt analysis (HRMA) (40). An sgRNA target site in a splice
donor site (AGCATGGGTACAGCCTAAGCAGG: sgRNA #742) was
chosen based on these data for generating clonal knockout N2A
lines. Two additional sgRNA, targeting either mid exon 4 or 5,
respectively, were tested to control for any off-target effects:
sgRNA #743 (TGGCAGAGGGCAAAGCGCTCAGG) and sgRNA #744
(TTTGAGTGGTCTTGATGAGCAGG). N2A cells in a 1.9cm2 well
were transfected for 36 h with Fugene 6 (Promega) followed by
treatment with 2.5 μg/ml puromycin for 48 h. The surviving cells
were plated in 63cm2 dishes to generate single cell clones. Cells
were grown 5–7 days until the appearance of colonies. Individual
colonies were trypsinized and reseeded to 1.9cm2 wells. Clones
were screened using HRMA with primers (F: AGACATTTGGTC
CTGGATCC and R: CAGCTACCCTATGATTTCCTG) using Hotshot
Diamond PCR mix (Clent Lifescience) with LCGreen plus dye
(BioFire Diagnostics) on a Light Scanner (Idaho Technology Inc).
Three independent clones were characterized phenotypically
for sgRNA #742, and one clone was characterized for sgRNA #743
and sgRNA #744, with similar results. Results for sgRNA #742
are presented only. The positive clones were tested for loss of
Tbc1d24 protein expression by western blotting. The identity of
the genomic indels was determined by cloning the critical region
into a TA-cloning vector (pcDNA4, Invitrogen) and sequencing 40
clones from each independent cell line. No WT sequences were
identified in any sample.
Modelling
Models for TLDc and TBC domains were individually built using
Modeller, provided sequence alignments produced with Clustal
Omega (41). The TBC domain was modelled using PDB 2Q88 as
template (22.93% sequence identity), while the TLDc domain
was built using PDB T4ACJ (34.76% sequence identity). For the
latter domain, sequence alignment indicates that a 47-amino
acid-long insertion is present between residue K448 and E495.
Secondary structure prediction by JPRED (42) indicates that the
region is dominated by random coil, besides a possible alpha
helix between residues P481 and A485 (i.e. 89.4% random coil).
This region was therefore omitted from the model, given the
high uncertainty about its location. Both models were indepen-
dently relaxed via molecular dynamics simulations using the
Amber ff14 force field (43), and the NAMD molecular dynamics
engine (44). Structures were solvated in a box of TIP3P water, and
the simulation boxes were neutralized by adding Na+ counte-
rions. In the case of the TLDc domain, the unfolded K448-E495
region was not included. The resulting systems were energy-
minimized via 2000 conjugate gradient steps, and equilibrated
for 1 ns in the nVT ensemble, at a pressure of 1 atm and
temperature of 300 K. A 2 fs time step was adopted, with all cova-
lent bonds controlled by SHAKE, a distance cutoff at 12 Å and
Particle Mesh Ewald to treat long-range electrostatic interac-
tions. Langevin dynamics were exploited to control temper-
ature and pressure, with a 0.1 ps−1 damping. Both systems
were then simulated for 50 ns in the nPT ensemble, and their
root-mean-square deviation (RMSD) and secondary structure
assessed against the initial structure every 0.1 ns. To analyze
the evolution of secondary structure, each simulation frame was
submitted to the DSSP software (45), and its output used to
determine the quantity of residues in structured regions. We
considered as structured all amino acids in an α-helix, β-bridge,
extended strand, 3–10 helix and π-helix conformation. We thus
derived the percentage of amino acids maintaining a structured
conformation on each simulation frame, as compared against
the initial structure. To characterize the neighborhood relation-
ships of disease-related amino acids, we calculated the pair-
wise distance between their α-carbons on the last structures of
both TBC and TLDc domains’ simulations. These distances were
then submitted to a Unweighted Pair Group Method with Arith-
metic Mean hierarchical clustering algorithm as implemented
in Python’s SciPy package. Image rendering was performed with
VMD (46).
Scanning electron microscopy
Inner ears were collected and processed for SEM, as previously
described (47). Briefly, mice were culled by cervical dislocation
and inner ears were removed and fixed in 2.5% glutaraldehyde in
0.1 M phosphate buffer. Following decalcification in 4.3% EDTA,
cochleae were sub-dissected to expose the sensory epithelia
and subjected to processing with an alternate incubation in
1% osmium tetroxide and 1% thiocarbohydrazide, before dehy-
dration in increasing concentrations of ethanol. Samples were
critical point dried using an Emitech K850 (EM Technologies
Ltd), mounted on stubs using silver paint (Agar Scientific) and
sputter coated with platinum using a Quorum Q150R S (Quorum
Technologies). Cochleae were examined using a JEOL JSM-6010LV
scanning electron microscope. Hair cell stereocilia bundle counts
were performed by counting the number of outer hair cell and
inner hair cell bundles adjacent to ten pillar cells in the apical
(<180◦ from apex), mid (180–450◦ from apex) and basal (> 450◦
from apex) regions of the cochlea. At least six ears (one ear per
mouse) were analysed for each genotype.
Auditory brainstem response
ABR testing was performed to investigate auditory function, as
described previously (47). Briefly, mice were anaesthetized with
a mixture of ketamine and xylazine and placed on a heated mat
inside a sound-attenuated chamber. Electrodes were placed sub-
dermally over the vertex (active), right mastoid (reference) and
left mastoid (ground). Broadband click and frequency-specific
tone-burst stimuli (8 kHz, 16 kHz and 32 kHz) were presented
free-field to the right ear of the mouse, starting at 90 decibel
sound pressure level (dB SPL) and decreasing in 5 dB increments.
ABR responses were collected, amplified and averaged using TDT
System 3 hardware (Tucker Davies Technology) and BioSigRZ
software. Auditory thresholds were defined as the lowest dB SPL
at which an ABR trace pattern could be clearly distinguished.
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Behavioural testing
As a measure of righting behaviour and related motor function,
mice at P6 were placed on their back with their limbs pointing
upwards and the time needed to turn over and restore their nor-
mal prone positions was recorded and averaged over three con-
secutive trials. As a measure of postural stability and mobility
test, or negative geotaxis, mice at P7 were placed on a grid, tilted
45◦ to the plane, with their head facing downwards. Animals that
could rotate a full 180◦, face up and could climb the grid within
a maximum time of 30 s were considered to have fully acquired
this reflex. To measure early development of locomotion, mature
walking behaviour was measured at P16 when the animal was
able to move its body completely supported by the four limbs
without dragging the belly over the surface over a 60 s trial. To
measure novelty-induced locomotor activity (LMA), experiments
were conducted in the light phase between 1000 and 1100 h.
Ambulations were measured in transparent plexiglass cages
(20 × 35 cm), equipped with infrared photobeams (San Diego
Instruments) over a total of 1 h. The central area was defined
as a region 10 × 15 cm in the arena.
In situ hybridization
A digoxigenin-labelled riboprobe was synthesized from lin-
earized plasmid pCR4-TOPO (Invitrogen; nucleotides 2705–
3558 of NM 001163847). Tissue samples were snap frozen in
Optimal Cutting Temperature and 15 μm sections were cut
using a cryostat (Leica) and mounted onto Superfrost Plus slides
(Avantor). Probe hybridization, washing and signal detection
using an alkaline phosphatase-conjugated anti-DIG antibody
was carried out as previously described (20).
Neonatal neuropathology
Mice were perfused transcardially with 0.1 M PBS, followed by 4%
PFA. Brains were dissected out and post-fixed in 4% PFA at 4◦C
overnight, then transferred to 30% sucrose for cryoprotection.
Brains were cut at 15 μm using a cryostat (Bright). For Nissl stain-
ing, sections at 60 μm intervals representing equivalent regions
of the somatosensory or motor cortex were quantified. For cor-
tical layer and hippocampal immunostaining of Tbc1d24WT and
Tbc1d24tm1b, five sections representing equivalent regions of the
somatosensory or motor cortex at 60 μm intervals were mounted
on slides and blocked in 5% donkey or goat serum in PBS with
0.3% Triton X-100. Primary antibodies were incubated in the
same blocking solution overnight at 4◦C. Immunostaining for
Tbr1 and Ctip2 required additional retrieval in 10 mM sodium
citrate (Sigma) pH 6.0 buffer for 20 min prior to blocking. The
appropriate secondary antibodies were applied for 2 h at room
temperature. Quantification of immunopositive cells was carried
out from a fixed field of view using an ImageJ plug-in using a
Leica microscope.
pHluorin dye analysis
Hippocampal neurons were transfected with 3 μg 2x SypH DNA
with Lipofectamine 2000 (Invitrogen) for 1 h before the medium
was replaced and neurons cultured for further 7 days before
assaying (48). Coverslips were mounted in a Chamlide stimula-
tion chamber (Live Cell Instrument, Seoul, Korea) on the stage of
an Olympus IX-71 inverted microscope fitted with a 100 X, NA
1.40 UPlanSApo objective and an Andor iXon EM CCD camera.
Fluorescence illumination was supplied by a 100 W mercury
lamp used with appropriate neutral density filters and shut-
tered (Uniblitz) during all non-data acquisition periods. A 460–
495 nm excitation/510–550 nm emission filter set was used for
pHluorins. APs were evoked by passing 40 V, 1 ms current pulses
from a custom-made stimulation box via platinum electrodes.
Stimulation, image acquisition and shuttering were all under the
co-ordinated control of WinWCP software. Imaging was carried
out at room temperature in a Tyrode’s buffer containing (in
mM): 119 NaCl, 2.5 KCl, 2 CaCl2, 2 MgCl2, 25 HEPES (pH 7.4)
and 30 glucose. 10 μM NBQX and 50 μM APV were added to
block recurrent activity. Where used, folimycin was added to
a final bath concentration of 8 nM. Images were analysed in
ImageJ using the Time Series Analyzer plugin. Visible varicosities
were selected for analysis with a 2 μm region of interest. Data
exported from ImageJ were background adjusted and normal-
ized to the mean baseline pre-stimulus signal in order to adjust
for differing pHluorin expression levels. Peak fluorescence in all
experiments was taken at the end of the stimulation period.
Analysis was performed in Microsoft Excel using custom-written
macros.
TEM of primary neurons
Cultured cortical neurons derived from Tbc1d24WT and
Tbc1d24Tm1b mice were fixed at 14–18 DIV with 1.2% glutaralde-
hyde in 66 mM sodium cacodylate buffer, post-fixed in 1% OsO4,
1.5% K4Fe(CN)6, 0.1 M sodium cacodylate, en bloc stained with
1% uranyl acetate, dehydrated and flat-embedded in epoxy resin
(Epon 812, TAAB). After baking for 48 h, the glass coverslips were
removed from the Epon block by thermal shock and neurons
were identified by means of a stereomicroscope. Embedded
neurons were excised from the block, and mounted on a cured
Epon block for sectioning using an EM UC6 ultramicrotome
(Leica Microsystems). Ultrathin sections (60–70 nm thick)
were collected on 200-mesh copper grids (Electron Microscopy
Sciences) and observed with a JEM-1011 electron microscope
(Jeol) operating at 100 kV using an ORIUS SC1000 CCD camera
(Gatan, Pleasanton). For each experimental condition, at least
30 images of synapses were acquired at 10 000× magnification
(sampled area per experimental condition: 36 μm2). Synaptic
profile area, SV number and distribution relative to the active
zone (AZ) were determined using ImageJ software. For the 3D
reconstruction, the standard TEM sample preparation protocol
was followed, and samples were embedded in Epon resin. Serial
60-nm-thick sections were collected on carbon-coated copper
slot formvar and carbon-coated grids, and serial synaptic profiles
acquired. Serial sections were aligned using Midas from IMOD
software. Synapses with one single AZ, at least one docked
SV and greater than 100 SVs were reconstructed with IMOD
software.
Electrophysiological recordings
Hippocampal neurons were recorded at 13–15 DIV. Patch
pipettes, prepared from thin borosilicate glass, were pulled
and fire-polished to a final resistance of 4–5 MΩ when filled
with standard internal solution. Current-clamp recordings
were performed at a holding potential of −70 mV, and AP
firing was induced by injecting current steps of 10 pA lasting
500 ms. Voltage-clamp recordings for spontaneous miniature
post-synaptic currents (mPSCs) were acquired at 10–20 kHz
sample frequency at the same holding potential. All experiments
were performed at room temperature. Data acquisition was
performed using PatchMaster program (HEKA Elektronic). For
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all experiments, cells were maintained in extracellular standard
solution (Tyrode) containing (in mM): 140 NaCl, 2 CaCl2, 1 MgCl2,
4 KCl, 10 glucose, and 10 HEPES (pH 7.3 with NaOH). All
reagents were bought from Tocris, unless otherwise stated.
For the analysis of neuronal excitability, recordings in current-
clamp configuration were performed in Tyrode extracellular
solution in which D-(−)-2-amino-5-phosphonopentanoic acid
(D-AP5; 50 μM), 6-cyano-7 nitroquinoxaline-2,3-dione (CNQX;
10 μM), bicuculline methiodide (30 μM) and (2S)-3-[[(1S)-1-(3,
4-dichlorophenyl)ethyl]amino-2-hydroxypropyl] (phenylmethyl)
phosphinic acid hydrochloride (CGP58845; 5 μM) were added to
block NMDA, non-NMDA, GABA-A and GABA-B receptors, respec-
tively. The internal solution (K-gluconate) was composed of
(in mM) 126 K gluconate, 4 NaCl, 1 MgSO4, 0.02 CaCl2, 0.1 BAPTA,
15 glucose, 5 HEPES, 3 ATP and 0.1 GTP (pH 7.3 with KOH). Spon-
taneous post-synaptic currents (PSCs) were recorded in voltage-
clamp configuration in the presence of TTX (300 nM) in the
extracellular solution to block the generation and propagation
of spontaneous APs. To isolate mEPSCs, bicuculline methiodide
and CGP58845 were added to Tyrode extracellular solution. The
amplitude and frequency of mEPSCs were calculated using a
peak detector function using different appropriate threshold
amplitude and area. The frequency, amplitude and kinetics of
miniature EPSCs were analysed using the MiniAnalysis program
and the Prism software (GraphPad Software, Inc.).
Synapse density quantification
Hippocampal neurons were fixed at 13–15 DIV, in 4% formalde-
hyde and 4% sucrose in phosphate-buffered saline (PBS) for
5 min at room temperature. Cells were then washed three times
in PBS, permeabilized and blocked for 30 mins in 5% FBS, 0.1%
Triton X-100 in PBS. Primary antibodies diluted in 5% FBS in
PBS were applied up to 2 h. Cultures were immunostained with
vGLUT1 and Homer1, with Alexa-conjugated secondary anti-
bodies and mounted using Prolong Diamond anti-fade reagent
with DAPI (Invitrogen). 18–35 z-stack for each image (step size
0.35 μm) were acquired. Image analyses were performed with
ImageJ superimposing stacks of each colour channel. The co-
localization analysis was performed by evaluating the labelling
of pre- and post-synaptic protein couples (vGLUT1/Homer1). Co-
localization puncta with areas of 0.1–2 μm2 were considered bona
fide synaptic boutons and their number per field automatically
counted evaluated by using the ImageJ colocalization plug-in.
Supplementary Material
Supplementary Material is available at HMG online.
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Lesca, G. et al. (2016) TBC1D24 genotype-phenotype corre-
lation: epilepsies and other neurologic features. Neurology,
87, 77–85.
D
ow
nloaded from
 https://academ
ic.oup.com
/hm
g/advance-article-abstract/doi/10.1093/hm
g/ddy370/5134216 by guest on 15 January 2019
Human Molecular Genetics, 2018, Vol. 00, No. 00 13
14. Uytterhoeven, V., Kuenen, S., Kasprowicz, J., Miskiewicz, K.
and Verstreken, P. (2011) Loss of Skywalker reveals synaptic
endosomes as sorting stations for synaptic vesicle proteins.
Cell, 145, 117–132.
15. Fernandes, A.C., Uytterhoeven, V., Kuenen, S., Wang, Y.-C.,
Slabbaert, J.R., Swerts, J., Kasprowicz, J., Aerts, S. and
Verstreken, P. (2014) Reduced synaptic vesicle protein
degradation at lysosomes curbs TBC1D24/sky-induced neu-
rodegeneration. J. Cell Biol., 207, 453–462.
16. Fischer, B., Lüthy, K., Paesmans, J., De Koninck, C., Maes, I.,
Swerts, J., Kuenen, S., Uytterhoeven, V., Verstreken, P. and
Versées, W. (2016) Skywalker-TBC1D24 has a lipid-binding
pocket mutated in epilepsy and required for synaptic func-
tion. Nat. Struct. Mol. Biol., 23, 965–973.
17. Falace, A., Buhler, E., Fadda, M., Watrin, F., Lippiello, P., Pallesi-
Pocachard, E., Baldelli, P., Benfenati, F., Zara, F., Represa, A.
et al. (2014) TBC1D24 regulates neuronal migration and
maturation through modulation of the ARF6-dependent
pathway. Proc. Natl. Acad. Sci. U S A, 111, 2337–2342.
18. Falace, A., Filipello, F., La Padula, V., Vanni, N., Madia, F., De
Pietri Tonelli, D., de Falco, F.A., Striano, P., Dagna Bricarelli, F.,
Minetti, C. et al. (2010) TBC1D24, an ARF6-interacting protein,
is mutated in familial infantile myoclonic epilepsy. Am. J.
Hum. Genet., 87, 365–370.
19. Corbett, M.A., Bahlo, M., Jolly, L., Afawi, Z., Gardner, A.E.,
Oliver, K.L., Tan, S., Coffey, A., Mulley, J.C., Dibbens, L.M. et al.
(2010) A focal epilepsy and intellectual disability syndrome
is due to a mutation in TBC1D24. Am. J. Hum. Genet., 87,
371–375.
20. Finelli, M.J., Sanchez-Pulido, L., Liu, K.X., Davies, K.E.
and Oliver, P.L. (2016) The evolutionarily conserved
Tre2/Bub2/Cdc16 (TBC), lysin motif (LYSM), domain catalytic
(TLDc) domain is neuroprotective against oxidative stress.
J. Biol. Chem., 291, 2751–2763.
21. Finelli, M.J. and Oliver, P.L. (2017) TLDc proteins: new players
in the oxidative stress response and neurological disease.
Mamm. Genome, 28, 395–406.
22. Campeau, P.M., Kasperaviciute, D., Lu, J.T., Burrage, L.C.,
Kim, C., Hori, M., Powell, B.R., Stewart, F., Félix, T.M.,
van den Ende, J. et al. (2014) The genetic basis of DOORS
syndrome: an exome-sequencing study. Lancet Neurol., 13,
44–58.
23. Lozano, R., Herman, K., Rothfuss, M., Rieger, H., Bayrak-
Toydemir, P., Aprile, D., Fruscione, F., Zara, F. and Fassio, A.
(2016) Clinical intrafamilial variability in lethal familial
neonatal seizure disorder caused by TBC1D24 mutations.
Am. J. Med. Genet. A, 170, 3207–3214.
24. Banuelos, E., Ramsey, K., Belnap, N., Krishnan, M., Balak, C.,
Szelinger, S., Siniard, A.L., Russell, M., Richholt, R., De Both,
M. et al. (2017) Case report: novel mutations in TBC1D24
are associated with autosomal dominant tonic-clonic and
myoclonic epilepsy and recessive Parkinsonism, psychosis,
and intellectual disability. F1000Res., 6, 553.
25. Rehman, A.U., Santos-Cortez, R.L.P., Morell, R.J., Drummond,
M.C., Ito, T., Lee, K., Khan, A.A., Basra, M.A.R., Wasif, N.,
Ayub, M. et al. (2014) Mutations in TBC1D24, a gene asso-
ciated with epilepsy, also cause nonsyndromic deafness
DFNB86. Am. J. Hum. Genet., 94, 144–152.
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